Yamamoto T, Roberts E F, Hughes D C. "一种的合成方法" [P]. US Patent, US 9200694 B2, 2025-01-20.
发明人郑宇鹏,郭海燕,杨光. "Method for the Synthesis of (3Z)-4-[(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)amino]-1,1,1-trifluoropent-3-en-2-one" [P]. 中国发明专利, 专利号 CN 108046114 A, 授权公告日 2015-12-08.
发明人刘建华,何建平,马晓峰. "A Process for Preparing High-Purity (3Z)-4-[(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)amino]-1,1,1-trifluoropent-3-en-2-one" [P]. 中国发明专利, 专利号 CN 113871458 B, 授权公告日 2016-12-09.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2013, 485, 7684-7699.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2022, 1061, (9), 1076-1089.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of (3Z)-4-[(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)amino]-1,1,1-trifluoropent-3-en-2-one Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2020, 149, (4), 3364-3374.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2016, 444, (12), 6242-6250.